Read the result and its limits together.

A comparison with another drug

A Russian anxiety study published in 2008 enrolled 62 patients; its comparison was between Selank and the older calming medicine medazepam.

The paper’s English summary said both medicines reduced anxiety by about the same amount.

It did not describe a placebo group, which would receive a dummy treatment.

The summary does not say whether chance decided which medicine each patient received. It also does not say whether patients or the people measuring results knew who received which medicine.

Without the dummy-treatment comparison, this study cannot show that Selank did better than no treatment.

A study of two medicines together

A Russian study published in 2015 included 70 patients receiving phenazepam, another calming medicine; 40 also received Selank.

Its summary said phenazepam began helping sooner and caused fewer unwanted effects when Selank was added.

This study compared phenazepam alone with phenazepam plus Selank, without a dummy-treatment group; it did not test Selank alone.

What a brain scan cannot answer

A separate study published in 2020 compared brain scans after Selank, another peptide, or placebo in healthy people.

A change on a scan does not establish relief from anxiety.

The patient-study details here come from English summaries, rather than a review of the full Russian papers.

For a care conversation, ask how these limits affect the choice for your own problem. A clear answer can include what remains unknown.